Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional

A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00087620

Public ClinicalTrials.gov record NCT00087620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate and compare the time to progression of the combination of capecitabine (825 mg/m2 twice daily) and docetaxel (75mg/m2 i.v.) to that of capecitabine (1000 mg/m2 twice daily) until progressive disease followed sequentially by docetaxel (75 mg/m2 i.v. D1 Q3W).

Study identification

NCT ID
NCT00087620
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2004 (Actual)
Primary completion
Oct 2004 (Actual)
Completion
Oct 2004 (Actual)
Last update posted
Feb 3, 2017

2004

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72205 —
Not listed Deer Park California 94576 —
Not listed Greenbrae California 94904 —
Not listed La Jolla California 92037 —
Not listed Los Angeles California 90057 —
Not listed Orange California 92868 —
Not listed Aurora Colorado 80010 —
Not listed Boca Raton Florida 33428 —
Not listed Boynton Beach Florida 33435 —
Not listed Brooksville Florida 34613 —
Not listed Hollywood Florida 33021 —
Not listed New Port Richey Florida 34652 —
Not listed Augusta Georgia 30901 —
Not listed Savannah Georgia 31405 —
Not listed Chicago Illinois 60611 —
Not listed Skokie Illinois 60077 —
Not listed Waterloo Iowa 50702 —
Not listed Lenexa Kansas 66214 —
Not listed Lafayette Louisiana 70503 —
Not listed Scarborough Maine 04074 —
Not listed Baltimore Maryland 21237 —
Not listed Prince Frederick Maryland 20678 —
Not listed Lansing Michigan 48909 —
Not listed Minneapolis Minnesota 55455 —
Not listed Reno Nevada 89502 —
Not listed Rochester New York 14642 —
Not listed Durham North Carolina 27710 —
Not listed Wilmington North Carolina 28401 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Florence South Carolina 29506 —
Not listed Corpus Christi Texas 78412 —
Not listed Richardson Texas 75080 —
Not listed Milwaukee Wisconsin 53215 —
Not listed Racine Wisconsin 53405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00087620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →